Artículos de revistas
Metabolic And Inflammatory Proteins Differentially Expressed In Platelets From Unprovoked Deep Vein Thrombosis Patients
Registration in:
Journal Of Proteomics And Bioinformatics. Omics Publishing Group, v. 7, n. 1, p. 17 - 22, 2014.
0974276X
10.4172/jpb.1000298
2-s2.0-84893628831
Author
Flores-Nascimento M.C.
Kleinfelder-Fontanesi K.
de Araujo T.M.
Forato Anhe G.
Secolin R.
Andrade Orsi F.
de Paula E.V.
Annichino-Bizzacchi J.M.
Institutions
Abstract
Deep vein thrombosis (DVT) is multi-causal disease associated to high morbidity and mortality due to complications, especially from pulmonary embolism. New factors of relevance on the DVT pathophysiology enhance our understanding of disease mechanisms and can be translated into improved management of patients, prevention of recurrence and development of new therapies. In this context, the precise role of platelets in the pathogenesis of DVT is not completely understood. Our objectives were to acquire and to analyze the whole platelet protein profile of samples from 3 DVT patients and to compare them to results obtained from 1 sibling and 1 neighbor from each patient (in order to minimize genetic and environmental interferences). These patients presented unprovoked and recurrent episodes of proximal DVT as well as a family history of DVT. Platelets were washed, lysed, and the proteins were hydrolyzed by trypsin. Peptides were first separated by HPLC and peptide fractions were further detected by LC-MS/MS. Five proteins was present on patients and absent in all the controls: Apolipoprotein A1 Binding-Protein, Coatomer (zeta1 sub-unit), 17β-hydroxysteroid dehydrogenase type XI, Leukotriene A-4 Hydrolase and Sorbitol Dehydrogenase. The analysis identified proteins that currently are not related to the pathophysiology of DVT, and the persistence of these inflammatory and lipid transportation-related proteins emphasize the relevance of these phenomena on DVT. © 2014 Flores-Nascimento MC, et al. 7 1 17 22 Silverstein, M.D., Heit, J.A., Mohr, D.N., Petterson, T.M., O'Fallon, W.M., Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study (1998) Arch Intern Med, 158, pp. 585-593 Hansson, P.O., Welin, L., Tibblin, G., Eriksson, H., Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913' (1997) Arch Intern Med, 157, pp. 1665-1670 Heit, J.A., Venous thromboembolism epidemiology: Implications for prevention and management (2002) Semin Thromb Hemost, 28, pp. 3-13 Lippi, G., Favaloro, E.J., Plebani, M., Proteomic analysis of venous thromboembolism (2010) Expert Rev Proteomics, 7, pp. 275-282 Flores-Nascimento, M.C., Paes-Leme, A.F., Mazetto, B.M., Zanella, J.L., De Paula, E.V., Inflammatory, immune and lipid transportation proteins are differentially expressed in spontaneous and proximal deep vein thrombosis patients (2012) Thromb Res, 130, pp. e246-250 Corral, J., Huntington, J.A., González-Conejero, R., Mushunje, A., Navarro, M., Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis (2004) J Thromb Haemost, 2, pp. 931-939 Gelfi, C., Viganò, A., Ripamonti, M., Wait, R., Begum, S., A proteomic analysis of changes in prothrombin and plasma proteins associated with the G20210A mutation (2004) Proteomics, 4, pp. 2151-2159 Svensson, A.M., Whiteley, G.R., Callas, P.W., Bovill, E.G., SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40 (2006) Thromb Haemost, 96, pp. 725-730 Munnix, I.C., Cosemans, J.M., Auger, J.M., Heemskerk, J.W., Platelet response heterogeneity in thrombus formation (2009) Thromb Haemost, 102, pp. 1149-1156 Nurden, A.T., Nurden, P., (2002) Inherited disorders of platelet function, , Academic Press. London, United Kingdom García, A., Prabhakar, S., Hughan, S., Anderson, T.W., Brock, C.J., Differential proteome analysis of TRAP-activated platelets: Involvement of DOK-2 and phosphorylation of RGS proteins (2004) Blood, 103, pp. 2088-2095 Marcus, K., Meyer, H.E., Two-dimensional polyacrylamide gel electrophoresis for platelet proteomics (2004) Methods Mol Biol, 273, pp. 421-434 Maguire, P.B., Wynne, K.J., Harney, D.F., O'Donoghue, N.M., Stephens, G., Identification of the phosphotyrosine proteome from thrombin activated platelets (2002) Proteomics, 2, pp. 642-648 Coppinger, J.A., Cagney, G., Toomey, S., Kislinger, T., Belton, O., Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions (2004) Blood, 103, pp. 2096-2104 Gevaert, K., Eggermont, L., Demol, H., Vandekerckhove, J., A fast and convenient MALDI-MS based proteomic approach: Identification of components scaffolded by the actin cytoskeleton of activated human thrombocytes (2000) J Biotechnol, 78, pp. 259-269 Ramacciotti, E., Hawley, A.E., Wrobleski, S.K., Myers Jr., D.D., Strahler, J.R., Proteomics of microparticles after deep venous thrombosis (2010) Thromb Res, 125, pp. e269-274 Cazenave, J.P., Ohlmann, P., Cassel, D., Eckly, A., Hechler, B., Preparation of washed platelet suspensions from human and rodent blood (2004) Platelets and Megakaryocytes-Methods in Molecular Biology, 272, pp. 13-28 Wojcechowskyj, J.A., Lee, J.Y., Seeholzer, S.H., Doms, R.W., Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling (2011) PLoS One, 6, pp. e24918 McNulty, D.E., Annan, R.S., Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection (2008) Mol Cell Proteomics, 7, pp. 971-980 Gnatenko, D.V., Perrotta, P.L., Bahou, W.F., Proteomic approaches to dissect platelet function: Half the story (2006) Blood, 108, pp. 3983-3991 Pignatelli, P., Pulcinelli, F.M., Ciatti, F., Pesciotti, M., Sebastiani, S., Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation (1995) J Clin Lab Anal, 9, pp. 138-140 Kozek-Langenecker, S.A., Spiss, C.K., Michalek-Sauberer, A., Felfernig, M., Zimpfer, M., Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration (2003) Crit Care Med, 31, pp. 864-868 Schrör, K., Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis (1997) Semin Thromb Hemost, 23, pp. 349-356 Semple, J.W., Italiano Jr., J.E., Freedman, J., Platelets and the immune continuum (2011) Nat Rev Immunol, 11, pp. 264-274 Qiu, H., Gabrielsen, A., Agardh, H.E., Wan, M., Wetterholm, A., Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability (2006) Proc Natl Acad Sci U S A, 103, pp. 8161-8166 Naruko, T., Ueda, M., Haze, K., van der Wal, A.C., van der Loos, C.M., Neutrophil infiltration of culprit lesions in acute coronary syndromes (2002) Circulation, 106, pp. 2894-2900 Zhang, R., Brennan, M.L., Fu, X., Aviles, R.J., Pearce, G.L., Association between myeloperoxidase levels and risk of coronary artery disease (2001) JAMA, 286, pp. 2136-2142 Schmitt, D., Shen, Z., Zhang, R., Colles, S.M., Wu, W., Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum (1999) Biochemistry, 38, pp. 16904-16915 Eiserich, J.P., Baldus, S., Brennan, M.L., Ma, W., Zhang, C., Myeloperoxidase, a leukocyte-derived vascular NO oxidase (2002) Science, 296, pp. 2391-2394 Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction (2006) Nat Genet, 38, pp. 68-74 Brereton, P., Suzuki, T., Sasano, H., Li, K., Duarte, C., Pan1b (17betaHSD11)-enzymatic activity and distribution in the lung (2001) Mol Cell Endocrinol, 171, pp. 111-117 Mendelsohn, M.E., Karas, R.H., The protective effects of estrogen on the cardiovascular system (1999) N Engl J Med, 340, pp. 1801-1811 Wang, X., Abdel-Rahman, A.A., Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts (2002) Am J Physiol Heart Circ Physiol, 282, pp. H2309-H2315 Damy, T., Ratajczak, P., Shah, A.M., Camors, E., Marty, I., Increased neuronal nitric oxide synthase-derived NO production in the failing human heart (2004) Lancet, 363, pp. 1365-1367 van Eickels, M., Grohé, C., Cleutjens, J.P., Janssen, B.J., Wellens, H.J., 17beta-estradiol attenuates the development of pressure-overload hypertrophy (2001) Circulation, 104, pp. 1419-1423 Robetorye, R.S., Rodgers, G.M., Update on selected inherited venous thrombotic disorders (2001) Am J Hematol, 68, pp. 256-268 Cohen, P.G., Estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1: An explanation for the postmenopausal hormone replacement therapy effects (2005) Med Hypotheses, 64, pp. 989-991 Gu, F., Aniento, F., Parton, R.G., Gruenberg, J., Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes (1997) J Cell Biol, 139, pp. 1183-1195 Beller, M., Sztalryd, C., Southall, N., Bell, M., Jäckle, H., COPI complex is a regulator of lipid homeostasis (2008) PLoS Biol, 6, pp. e292 Dekroon, R.M., Armati, P.J., Synthesis and processing of apolipoprotein E in human brain cultures (2001) Glia, 33, pp. 298-305 Ritter, M., Buechler, C., Boettcher, A., Barlage, S., Schmitz-Madry, A., Cloning and characterization of a novel apolipoprotein A-I binding protein, AIBP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I (2002) Genomics, 79, pp. 693-702 Talens, S., Hoekstra, J., Dirkx, S.P., Darwish Murad, S., Trebicka, J., Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome (2011) J Hepatol, 54, pp. 908-914 Nordøy, A., Svensson, B., Hansen, J.B., Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia (2003) J Thromb Haemost, 1, pp. 690-697 Miller, G.J., Postprandial lipaemia and haemostatic factors (1998) Atherosclerosis 141 Suppl, 1, pp. S47-S51 Anderson, R.A., Jones, C.J., Goodfellow, J., Is the fatty meal a trigger for acute coronary syndromes (2001) Atherosclerosis, 159, pp. 9-15 Kostapanos, M.S., Christogiannis, L.G., Bika, E., Bairaktari, E.T., Goudevenos, J.A., Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects (2010) J Stroke Cerebrovasc Dis, 19, pp. 497-502 Jin, F.Y., Kamanna, V.S., Kashyap, M.L., Estradiol stimulates apolipoprotein A-I-but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells (1998) Arterioscler Thromb Vasc Biol, 18, pp. 999-1006 Jha, K.N., Shumilin, I.A., Digilio, L.C., Chertihin, O., Zheng, H., Biochemical and structural characterization of apolipoprotein A-I binding protein, a novel phosphoprotein with a potential role in sperm capacitation (2008) Endocrinology, 149, pp. 2108-2120 Lo, A.C., Cheung, A.K., Hung, V.K., Yeung, C.M., He, Q.Y., Deletion of aldose reductase leads to protection against cerebral ischemic injury (2007) J Cereb Blood Flow Metab, 27, pp. 1496-1509 Tang, W.H., Wu, S., Wong, T.M., Chung, S.K., Chung, S.S., Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart (2008) Free Radic Biol Med, 45, pp. 602-610